Hennion & Walsh Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.66M	Buy	8,684 +68	+0.8%	+$34.8K	0.13%	198
2026 Q1	$4.51M	Buy	8,616 +453	+6%	+$216K	0.15%	170
2025 Q4	$4.75M	Sell	8,163 -4,684	-36%	-$2.39M	0.16%	154
2025 Q3	$5.89M	Buy	12,847 +172	+1%	+$64.2K	0.21%	104
2025 Q2	$3.84M	Buy	12,675 +1,666	+15%	+$496K	0.15%	162
2025 Q1	$3.65M	Buy	11,009 +1,105	+11%	+$363K	0.16%	162
2024 Q4	$3.06M	Sell	9,904 -9,013	-48%	-$2.54M	0.14%	186
2024 Q3	$4.01M	Sell	18,917 -1,420	-7%	-$363K	0.19%	132
2024 Q2	$5.7M	Sell	20,337 -11,981	-37%	-$2.85M	0.29%	67
2024 Q1	$8.63M	Buy	32,318 +5,392	+20%	+$1.27M	0.46%	31
2023 Q4	$6.23M	Sell	26,926 -9,046	-25%	-$1.58M	0.36%	52
2023 Q3	$5.25M	Sell	35,972 -1,622	-4%	-$305K	0.34%	59
2023 Q2	$8.68M	Sell	37,594 -9,085	-19%	-$2.46M	0.52%	30
2023 Q1	$11.3M	Buy	46,679 +736	+2%	+$201K	0.69%	18
2022 Q4	$13.3M	Sell	45,943 -5,064	-10%	-$495K	0.82%	11
2022 Q3	$3.31M	Sell	51,007 -8,336	-14%	-$579K	0.22%	122
2022 Q2	$4.25M	Sell	59,343 -14,391	-20%	-$1.06M	0.26%	95
2022 Q1	$7.24M	Buy	73,734 +4,473	+6%	+$377K	0.38%	62
2021 Q4	$5.87M	Sell	69,261 -4,675	-6%	-$384K	0.29%	96
2021 Q3	$5.9M	Buy	73,936 +372	+0.5%	+$32.1K	0.31%	78
2021 Q2	$7.17M	Buy	73,564 +1,222	+2%	+$145K	0.38%	60
2021 Q1	$8.46M	Buy	+72,342	New	+$8.43M	0.51%	33

Other funds holding MDGL